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Abstract 
Depression is the leading cause of disability in the United States. Insufficient evidence is 
available about the types of follow-up care that may be most effective. The purpose of 
this quantitative, retrospective cohort study was to determine whether remission of 
depression symptoms was associated with recommended follow-up care when controlling 
for age, gender, and number of previous episodes of depression, and whether symptom 
reduction was more likely for those who completed a course of treatment from a mental 
health specialist in comparison to those who were treated by their primary care providers 
(PCPs) when controlling for the same variables. The theoretical framework for this study 
was Reingold’s theory of outbreak investigations. Existing was retrieved from Geisinger 
Health System’s electronic health record. The following covariates were evaluated for 
their effects on the re 
lationship between positive depression screening and follow-up care: baseline (initial) 
depression screening score, date of service, age, gender, consecutive depression screening 
score, date of consecutive depression screening, outcomes, and documented previous 
history of depression. Retrospective cohort data from 1,246 patients were collected from 
the study site and analyzed using descriptive statistics, t tests, ANOVAs, and multiple 
linear regression. Findings showed that PCP-initiated medication change and referral to 
community health were significantly associated with successful intervention. Findings 
may be used to encourage routine depression screening and increase positive health 
outcomes for patients with depression.  
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Section 1: Foundation of the Study and Literature Review 
In January 2016, the U.S. Preventive Services Task Force (USPSTF) recommended 
screening for depression in all adults (Siu & USPSTF, 2016). Their recommendation was to 
screen patients before they presented with depression-like symptoms while using a validated 
screening tool (Siu & USPSTF, 2016). They also recommend that although screening is 
important, it is also vital to ensure that accurate diagnosis, a plan of care, and routine follow-up 
are put in place for treatment to be effective (Siu & USPSTF, 2016).  
Because depression is one of the leading reasons for disability in the United States, it can 
be greatly beneficial to screen patients for any type of signs or symptoms of depression (Siu & 
USPSTF, 2016). Depression can create difficulties at work and in people’s personal lives (Siu & 
USPSTF, 2016). However, screening is just the beginning. Follow-up care is a crucial element in 
ensuring that patients are receiving quality care that is effective. As indicated by Olfson, Bianco, 
and Marcus (2016), 72% of patients who screen positive for depression are not getting the 
follow-up care required to effectively manage and/or treat their mental illness. 
 
Problem Statement 
In a U.S. survey, 35% of people with severe depression symptoms reported that they had 
had no care from a medical professional in the past year (Pratt & Brody, 2014). Routine follow-
up care is essential in managing mental illness, especially depression (Pratt & Brody, 2014). 
Mental illness is a burden on society and is the leading cause of disability across the world 
(World Health Organization [WHO], 2016a). However, insufficient evidence is available about 
the type of follow-up care that may be the most cost-effective. Some patients are referred to 
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mental health specialists and complete a course of treatment, others are referred but do not 
complete the treatment, others are treated entirely by their primary care provider, and some may 
decline any treatment (Pratt & Brody, 2014). The current study was designed to fill a gap in 
understanding by focusing on the outcomes of treatment after testing positive during depression 
screening (see Pratty & Brody, 2014).  
Purpose of the Study 
The purpose of this study was to determine whether remission of depression symptoms 
was associated with recommended follow-up care. This study was unique because by addressing 
the problem of depression and proposing a way in which primary care providers can play a role 
in screening and managing patients with depression. The results of this study may improve 
understanding of the vital role of primary care physicians in mental health. Given the limited 
resources available in the mental health profession, findings may be used to ensure patients are 
receiving high-quality mental health services. 
Depression accounts for 4.3% of the global burden of disease and is the largest cause of 
disability worldwide, particularly for women (WHO, 2016). Depression also causes a great 
burden on the economy (WHO, 2016). The total global impact of mental disorders is estimated 
to be $16.3 million between 2011 and 2030 (WHO, 2016). Through the creation of a systematic 
approach for routine depression screening and a standard of care for primary care physicians, the 
effects of this disease on health, comorbidity, and the economy may be reduced. 
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Research Questions and Hypotheses 
Research Question 1: Among patients who are screened as positive for depression, is 
symptom reduction more likely for those who receive treatment when controlling for age, 
gender, and number of previous episodes of depression? 
H01: There is no statistically significant association between untreated and treated 
patients in symptom reduction when controlling for age, gender, and number of previous 
episodes of depression. 
Ha1: There is a statistically significant association between untreated and treated patients 
in symptom reduction when controlling for age, gender, and number of previous episodes of 
depression. 
Research Question 2: Among patients who are screened as positive for depression, is 
symptom reduction more likely for those who complete a course of treatment from a mental 
health specialist in comparison to those who are treated by their primary care providers when 
controlling for age, gender, and number of previous episodes of depression? 
H02: There is no statistically significant association between symptom reduction and 
completing a course of treatment from a mental health specialist in comparison to not completing 
treatment when controlling for age, gender, and number of previous episodes of depression. 
Ha2: There is no statistically significant association between symptom reduction and 
completing a course of treatment from a mental health specialist in comparison to not completing 
treatment when controlling for age, gender, and number of previous episodes of depression. 
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Theoretical Framework 
The theoretical framework for this study was Reingold’s (1998) theory of outbreak 
investigations. Because this theory provides an approach to investigation of outbreaks using 
epidemiological principles, it allows for a thorough analysis of hypotheses and can ultimately aid 
in creating prevention measures (Reingold, 1998). The approach provides details on how to 
properly investigate outbreaks to design prevention measures and educate the public (Reingold, 
1998). Research and application of Reingold’s theory of outbreak investigation offered guidance 
on ways to facilitate standards for screening for primary care physicians as well as standards for 
follow-up care, thereby allowing for insight into the gap in care around depression by primary 
care physicians (see Reingold, 1998). 
In the current study, unresolved depression was the outbreak. Reingold (1998) provided 
epidemiological principles that allowed for analysis of the hypotheses and to create prevention 
measures. Moreover, using this model, implementation of control measures could be applied to 
people with a depression diagnosis to prove the theory of reduction of symptoms once treatment 
has started. 
Nature of the Study 
When it comes to follow-up care for depression, often patients with a positive depression 
screening do not have follow-up care. The concept of standardizing care is something many 
regulatory bodies are attempting, such as NCQA and accountable care organizations (Health 
Affairs, 2014). To be effective with the care that is provided in depression treatment, there needs 
to be a standard of care (MacArthur Foundation, 2009). From my secondary data source, I 
extracted the patients who screened positive for depression through a total score of 10 or higher 
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on the Patient Health Questionnaire-9. Using evidence-based follow-up guidelines, I compared 
patients who received recommended follow-up visits for 1 year and patients who did not receive 
recommended care. This approach helped to validate treatment guidelines or point to 
modifications (see MacArthur Foundation, 2009). 
Literature Search Strategy 
The following Walden University Library databases were used for this study: Walden 
Library Books, PubMed, CINAHL Plus with Full Text, MEDLINE with Full Text, Cochrane 
Database of Systematic Reviews, Dissertations & Theses, Dissertations & Theses at Walden 
University, ProQuest Central, SAGE Knowledge (formerly SAGE Encyclopedias), SAGE 
Research Methods Online, SAGE Stats, Science Journals, and ScienceDirect. I also used Google 
Scholar, Google, and the WHO, UNICEF, and CDC websites. The following key terms were 
used for the search: depression, mental health, anxiety, depression follow up, depression 
outcomes, primary care, psych, depression management, PHQ2, PHQ9, depression screening, 
collaborative care model, depression clinical outcomes, depression remission, depression and 
geriatric patients, depression and comorbid conditions, WHO report, and CDC outcome reports. 
Although I conducted an open-ended search for literature, emphasis was placed on peer-
reviewed primary publications spanning a period of 5 years (2011-2016). In addition, national 
documents, WHO reports, and CDC reports were used to augment the literature review.  
Literature Review Related to Key Variables and/or Concepts 
Population 
In a national survey, 35% of people with severe depression symptoms reported that they 
had no care from a medical professional in the past year (Pratt & Brody, 2014). Routine follow-
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up care is essential in managing mental illness, especially depression (Pratt & Brody, 2014). 
Mental illness is a burden on society and is the leading cause of disability across the world 
(WHO, 2016). This study was designed to fill a gap in the literature by focusing on depression 
screening and insufficient coordination of follow-up care.  
Olfson et al. (2016) reviewed 46,000 patients who screened positive for depression. The 
results indicated that only 28% had a follow-up. Follow-up interventions included monitoring, 
psychotherapy or counseling, exercise and yoga, pharmacological treatment, and combinations 
of treatments. In patients who had serious psychological distress, the results showed that only 
21% were treated.  
Significance 
Depression accounts for 4.3% of the global burden of disease and is the largest cause of 
disability worldwide, particularly for women (WHO, 2016). Depression also causes a great 
burden on the economy (WHO, 2016). The total global impact of mental disorders is estimated 
to be $16.3 million between 2011 and 2030 (WHO, 2016). Through a systematic approach for 
routine screening for depression and a standard of care for primary care physicians, the effects of 
this disease on health, comorbidity, and the economy may be reduced.  
Nationally Validated Screening Tools 
Patient-administered screening tools are quick and reliable for patients. This is a natural 
first step in assessing patients for depression and monitoring treatment (Bienenfeld & Stinson, 
2016). Once a patient-administered screening tool is used, clinical review is required as a follow-
up to make a diagnosis (Bienenfeld & Stinson, 2016). The Diagnostic and Statistical Manual of 
Mental Disorders (DSM-5) criteria for major depression indicates that at least five symptoms 
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must be present within the previous 2 weeks (Bienenfeld & Stinson, 2016). Those symptoms 
include depressed mood, marked diminished interest or pleasure, significant weight loss or 
weight gain, insomnia or hypersomnia, fatigue, feelings of worthlessness or excessive guilt, 
inability to concentrate, or recurrent thoughts of death or suicidal ideation (Bienenfeld & 
Stinson, 2016).  
Through my literature review, I located many questionnaires available for use in 
identifying an underlying depression disorder, including the Hamilton Depression Rating Scale, 
Beck Depression Inventory, Patient Health Questionnaire (PHQ), Major Depression Inventory, 
Center for Epidemiologic Studies Depression Scale, Zung Self-Rating Depression Scale, 
Geriatric Depression Scale, and Cornell Scale for Depression in Dementia (Bienenfeld & 
Stinson, 2016). The Patient Health Questionnaire could provide the foundation for an 
examination of depression as a syndrome (Zimmerman et al., 2008). The PHQ is the 
recommended screening tool from the National Committee for Quality Assurance. The PHQ is 
validated starting at age 12 years (Zimmerman et al., 2008).  
Adolescents are required to complete the PHQ-9 modified for teens questionnaire 
(Zimmerman et al., 2008). Adult patients may be screened using the PHQ-2, which is a two-
question screening tool (Zimmerman et al., 2008). If the patient completes the questionnaire and 
receives a total score of 3 or higher, it is recommended the patient then complete the PHQ-9 for a 
recommended treatment plan (Zimmerman et al., 2008). This questionnaire is used to assess 
patients for depleted interest or pleasure in doing things as well as feelings of depression or 
hopelessness. The results allow the clinical team to understand the patient’s level of depression 
while providing for the effectiveness of treatment (See Appendix A). Measurement is an overall 
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score from the questions answered. A total score of 10 or higher signifies a positive screen, 
requiring a physician’s intervention to create a treatment plan. The depression score ranges are as 
follows: 5 to 9 (mild), 10 to 14 (moderate), 15 to 19 (moderately severe), 20 or higher (severe). 
Screening Outcomes 
There are many reasons to measure outcomes for screening, including quality patient 
care, regression of symptoms, identification of new symptoms, and treatment adjustments. 
Studies showed that many patients are on an antidepressant for several months and are not seeing 
any benefits (Zimmerman et al., 2008). Regression of symptoms may occur after initial 
treatment; however, symptoms may not have significantly changed and therefore additional 
treatment or a change in treatment may be required (Zimmerman et al., 2008). Patients who 
refuse treatment or drop out of treatment, typically do so within the first 6 months of initiating 
treatment (Zimmerman et al., 2008). 
Challenges of Screening for Depression 
Several researchers have identified a weak standardization in routine screening for 
depression within primary care settings (Gill et al., 2012; Loeb et al., 2015). The USPSTF (2016) 
and The National Committee for Quality Assurance (2016) added depression screening as a 
recommendation for the general population in January 2016. This recommendation has brought 
forth the recognition that depression screening should be standard. However, this is a newly 
implemented recommendation, and little literature exists regarding the outcomes.  
 Another challenge in screening for depression is access to behavioral health specialists. 
Olfson et al. (2016) reviewed 46,000 patients who screened positive for depression. The results 
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indicated that only 28% had a follow-up. For patients who had serious psychological distress, the 
results showed that only 21% were treated.  
Contributing Factors Leading to Depression 
Gender. Men are less likely to develop depression. In fact, women are twice as likely to 
develop depression during their lifetime (Bracken & Reintjes, 2010). Hammen and Padesky (as 
cited in Bracken & Reintjes, 2010) claimed that there was no significant difference between men 
and women when it came to depression symptoms. This was based on a study including 972 men 
and 1,300 women (Bracken & Reintjes, 2010). Nolen-Hoeksema (as cited in Bracken & Reintjes, 
2010) reported that there were no gender differences with depression symptoms until age 65.  
Age. Many studies have been conducted to determine whether age is a contributing factor 
in depression. Mirowsky and Ross (1990) found a relationship between age and depression. 
Results indicated the lowest number of depressed people were around 45 years old (Mirowsky & 
Ross, 1990). However, depression reached its peak in adults 80 years and older (Mirowsky & 
Ross, 1990).  
A more recent study showed that age does not necessarily have a significant impact on a 
person’s mental health (Bracken & Reintjes, 2010). Bracken and Reintjes (2010) conducted a 
study of 1,900 adults and children, with even distribution between sexes. Using the Clinical 
Assessment of Depression, Bracken and Reintjes found no significant differences in depression 
levels among different age groups. Although older adults were more likely to show depression 
symptoms, it was not solely based on their age. Instead, depression symptoms were linked to 
comorbid conditions (Bracken & Reintjes, 2010). 
Race/ethnicity. White participants showed significantly lower mean scores than Black 
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participants (Bracken & Reintjes, 2010). However, there was no difference between Black and 
Hispanic participants (Bracken & Reintjes, 2010). There were also no race/ethnicity differences 
for depressed mood or anxiety (Bracken & Reintjes, 2010). Regarding diminished interest, White 
participants scored significantly lower than Black participants, and Hispanics scored 
significantly lower than White participants (Bracken & Reintjes, 2010). 
Socioeconomic status. Low socioeconomic status was associated with a high likelihood 
of depression (Lorant et al., 2003). Low social status and low income, in conjunction with low 
access to health care and a higher likelihood of disease, led to a higher likelihood of depression 
among this subgroup (Lorant et al., 2003). Higher income and higher education showed a lower 
likelihood of depression (Lorant et al., 2003). 
Marital status. Out of a sample of 1,407 Black women, there was a relationship between 
marital status and depression. Women who were never married showed significantly higher 
levels of depression compared to those who were married or who were living with a partner 
(Scarini et al., 2002). Divorced couples also showed a higher significance of depression (Bruce 
& Kim, 1992). Men showed a greater risk of first-onset major depression after divorce (Bruce & 
Kim, 1992). 
Operational Definitions 
Anxiety and ADHD: According to the National Institute of Mental Health, anxiety 
disorders and attention-deficit hyperactivity disorder (ADHD) are often diagnosed among people 
with bipolar disorder. 
Behavioral health specialist: A behavioral health specialist, as part of the primary care 
treatment team, identifies triage and manages patients with medical and behavioral health 
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problems within the primary care setting. In addition, the behavioral health specialist provides 
skill training through psychoeducation and patient education strategies and develops specific 
behavioral change plans for patients and behavioral health protocols for target populations. 
Bipolar disorder: According to the National Institute of Mental Health, bipolar disorder 
is different from depression, but it is included in this list is because someone with bipolar 
disorder experiences episodes of extremely low moods that meet the criteria for major depression 
(called “bipolar depression”). However, a person with bipolar disorder also experiences extreme 
high (euphoric or irritable) moods called mania or a less severe form called hypomania. 
Depression: According to the National Institute of Mental Health, depression (major 
depressive disorder or clinical depression) is a common but serious mood disorder. It causes 
severe symptoms that affect how a person feels, thinks, and handles daily activities such as 
sleeping, eating, or working. To be diagnosed with depression, the symptoms must be present for 
at least 2 weeks. 
Perinatal depression: According to the National Institute of Mental Health, perinatal 
depression is much more serious than the “baby blues” (relatively mild depressive and anxiety 
symptoms that typically clear within 2 weeks after delivery) that many women experience after 
giving birth. Women with perinatal depression experience full-blown major depression during 
pregnancy or after delivery (postpartum depression). The feelings of extreme sadness, anxiety, 
and exhaustion that accompany perinatal depression may make it difficult for these new mothers 
to complete daily care activities for themselves and/or for their babies. 
Persistent depressive disorder: According to the National Institute of Mental Health, 
persistent depressive disorder (also called dysthymia) is a depressed mood that lasts for at least 2 
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years. A person diagnosed with persistent depressive disorder may have episodes of major 
depression along with periods of less severe symptoms, but symptoms must last for 2 years to be 
considered persistent depressive disorder. 
Psychosis: According to the National Institute of Mental Health, psychosis includes 
severe episodes of mania or depression and psychotic symptoms such as hallucinations or 
delusions. The psychotic symptoms tend to match the person’s extreme mood. Someone having 
psychotic symptoms during a manic episode may believe she or he is famous, has a lot of money, 
or has special powers. Someone having psychotic symptoms during a depressive episode may 
believe he or she is ruined and penniless, or that he or she has committed a crime. People with 
bipolar disorder who also have psychotic symptoms are sometimes misdiagnosed with 
schizophrenia. 
Psychotic depression: According to the National Institute of Mental Health, psychotic 
depression occurs when a person has severe depression plus some form of psychosis, such as 
having disturbed false fixed beliefs (delusions) or hearing or seeing upsetting things that others 
cannot hear or see (hallucinations). The psychotic symptoms typically have a depressive theme 
such as delusions of guilt, poverty, or illness. 
Seasonal affective disorder (SAD): According to the National Institute of Mental Health, 
SAD is characterized by the onset of depression during the winter months when there is less 
natural sunlight. This depression generally lifts during spring and summer. Winter depression, 
typically accompanied by social withdrawal, increased sleep, and weight gain, occurs predictably 
every year in seasonal affective disorder. 
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Substance Abuse: According to the National Institute of Mental Health, people with 
bipolar disorder may also misuse alcohol or drugs, have relationship problems, or perform poorly 
in school or at work. Family, friends, and people experiencing symptoms may not recognize 
these problems as signs of a major mental illness such as bipolar disorder. 
Literature Table Summary 
The table below gives an in-depth view of the studies that were reviewed to fully research 
this topic. Although there are many articles written about mental health and the importance of 
screening, proactive depression screening recommendations from the United States Preventive 
Task Force were only introduced in 2016 (United States Preventive Services Task Force, 2016). 
Loeb et al. (2015) wrote a compelling article that explained the importance of screening in 
primary care, citing that primary care physicians are fully equipped to screen and treat those with 
mild to moderate depression without having to offer psychiatric services.  
There are many protocols in place that helps primary care physicians understand the basics of 
treating those who have mild to moderate depression, such as The MacArthur Initiative on 
Depression and Primary Care (2009). This tool kit was comprised to help support primary care 
physicians in caring for patients who suffer from depression. They used recommendations that 
were first created by the US Preventive Service Task Force and NIMH guidelines to create a care 
management process. The kit provides easy to use tools to assist with many areas, recognizing 
and diagnosing depression, educating patients about depression, engaging participation, 
treatment options and monitoring for response of treatment (MacArthur Foundation., 2009). 
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Table 1 
 
Summary of Literature on Depression Screening, Treatment Recommendations, and Outcomes 
Author & 
Year 
Title 
 
Study Design Study Population Independent Variable Dependent 
variables 
Results Other 
Angstman, K., 
Rohrer, J., 
Rasmussen, 
N. (2012) 
PHQ-9 Response Curve: 
Rate of Improvement for 
Depression Treatment 
with Collaborative Care 
Management 
Retrospective 
Cohort Study 
7340 patients with 
depression cared 
for at 4 outpatient 
primary care 
clinics 
Collaborative Care 
Management Patients 
& Usual Care Patients 
Remission of 
Depression 
and persistent 
depressive 
symptoms 
This study demonstrated that 
patients enrolled in CCM have a 
faster rate of remission and a 
shorter duration of PDSs than 
patients choosing UC. 
 
Angstman, K., 
et al. (2014) 
Depression Remission 
Decreases Outpatient 
Utilization at 6 and 12 
months after Enrollment 
into Collaborative Care 
Management. 
Retrospective 
Chart Review 
Analysis 
773 patients 
enrolled into 
CCM with 6- and 
12-month follow-
up data 
Follow Up at 6 and 9 
months 
outpatient 
visit outlier 
status 
remission at 6 months (odds ratio 
[OR] 0.519, CI [confidence 
interval] 0.349-0.770, P=0.001) 
and remission at 12 months (OR 
0.573, CI 0.354-0.927, P=0.023) 
were predictive. With this inverse 
relationship between remission and 
outlier status, those patients who 
were not in remission had an OR of 
1.928 for outpatient visit outlier 
status at 6 months after enrollment 
and an OR of 1.745 at 12 months 
 
 
 
Ganguly, S., 
et al. (2012) 
Patient Health 
Questionnaire -9 as an 
Effective Tool for 
Screening for Depression 
Among Indian 
Adolescents 
PHQ9 
Randomized 
Survey 
233 adolescent 
students aged 14-
18 years of age 
with a confirmed 
diagnosis of 
depression 
 
 
 
 
 
 
 
Students Depression PHQ9 showed to be a successful 
tool to use with adolescent for early 
detection of mental illness. 
 
 
 
 
 
 
 
 
(table continues) 
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Author & 
Year 
Title 
 
Study Design Study Population Independent Variable Dependent 
variables 
Results Other 
Gill, J., et al. 
(2012) 
Electronic Clinical 
Depression Support for 
Management of 
Depression in Primary 
Care: A Prospective 
Cohort Study. 
Prospective 
Cohort Study 
19 primary care 
practices with 119 
providers 
PHQ-9 Questionnaire PHQ-9 
Results 
the PHQ-9 form was used in 45.6% 
of the 16,052 adult patients with 
depression and in 73.7% of the 
1,422 patients with new depression. 
Many providers reported 
often using the PHQ-9 
and suicide forms and felt 
them to be very helpful in 
patient care, with 85% 
planning to continue their 
use after the study. 
Loeb, D., et 
al. (2015) 
Evaluation of the Role of 
Training in the 
Implementation of a 
Depression Screening 
and Treatment Protocol 
in 2 Academic Outpatient 
Internal Medicine Clinics 
Utilizing the Electronic 
Medical Record. 
Retrospective 
Cohort Study 
58 providers 
answered the 
survey 
provider type 
(resident/faculty), 
clinic site 
(Anschutz/Lowry), 
and training 
attendance (yes/no) 
Survey The Collaborative Care Model, as 
well as other integrated care 
models, improves management of 
psychiatric illness within the 
primary care setting 
 
 
 
 
 
 
 
 
Meunier, M., 
et al. (2014) 
Impact of Symptom 
Remission on Outpatient 
Visits in Depressed 
Primary Care Patients 
Treated with 
Collaborative Care 
Management and Usual 
Care. 
Retrospective 
Chart Review 
Analysis 
1733 primary care 
patients enrolled 
in collaborative 
care management 
or usual care with 
6-month follow 
up data 
Clinical remission at 6 
months, enrollment 
into CCM or UC 
Decrease in 
outpatient 
visit counts 
after 
diagnosis of 
depression 
Patients treated in primary care, 
who had remission (PHQ-9 score < 
5) at 6 months decreased the 
likelihood of the patient having 
more than 8 visits during the 6 
months after diagnosis 
 
Olfson, M., 
Bianco, C., 
Marcus, S. 
(2016) 
Treatment of Adult 
Depression in the United 
States 
Retrospective 
Cohort Study 
46,417 responses 
surveys taken in 
US households by 
participants aged 
18 years or older 
in 2012 and 2013 
Treatment, recurrence 
of depression 
symptoms 
PHQ9 Score Approximately 8.4% (95% CI, 7.9-
8.8) of adults screened positive for 
depression, of which 28.7% 
received any depression treatment 
Among all adults treated 
for depression, 29.9% had 
screen-positive 
depression and 21.8% 
had serious psychological 
distress 
 
             (table continues) 
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Author & 
Year 
Title 
 
Study Design Study Population Independent Variable Dependent 
variables 
Results Other 
O’Connor, E., 
et al. (2009) 
Screening for Depression 
in Adult Patients in 
Primary Care Settings: A 
Systematic Evidence 
Review 
Retrospective 
Analysis 
9 good quality 
trials. 7 regulatory 
reviews or 
metaanalyses and 
3 large cohort 
studies 
Mental health Depression Depression screening programs 
without substantial staff-assisted 
depression care supports are 
unlikely to improve depression 
outcomes.  
Close monitoring of all 
adult patients who initiate 
antidepressant treatment, 
particularly those 
younger than 30 years, is 
important both for safety 
and to ensure optimal 
treatment 
Reeves, W., et 
al. (2011) 
Mental Illness 
Surveillance Among 
Adults in the United 
States 
Retrospective 
Cohort Study 
CDC Data from 
2005-2008 
Mental health Depression Future mental illness surveillance 
should measure both depression 
and anxiety disorders 
BRFSS and PRAMS can 
help identify areas in 
more need 
Rohrer, J., 
Angstman, K., 
Pecina, J. 
(2013) 
Application of a case-
control design to the 
analysis of a drop-outs 
from integrated 
behavioral health care. 
Case-Control Drop outs from all 
cases discharged 
patients 
Collaborative Care 
Patients 
Follow up Dropping out was associated with 
female sex (P=0.015), younger age 
(P=0.000) and treatment site 
(P=0.004) 
Sites still in the shake-
down period had higher 
drop-out rates. 
Depression diagnosis and 
severity were not 
significant. 
Zimmerman, 
Mark. (2013) 
Using Scales to monitor 
symptoms and treat 
depression (measurement 
based care) 
Retrospective 
Analysis 
12 controlled 
trials (10 random) 
– 5458 patients 
with different 
mental health 
disorders 
Other mental health 
disabilities 
Patients with 
Depression 
Inconsistent scale used to monitor 
treatment. Too many varieties of 
screening tools. 
Recommendation for 
screenings to be done 
consistently at each visit. 
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Literature Summary  
Throughout the literature study there are four major themes; collaborative care 
management, standardized screening, clinical standards for follow up and patient education on 
the importance of mental health. Collaborative care management allows for patients to receive 
subsequent treatment using various care team members. The below literature shows that through 
this method, there are better outcomes for patients. Additionally, it is important to use a standard 
tool for screening patients with depression. The PHQ-9 showed to be an effective tool when 
compared to the Beck Depression Inventory survey. Clinical standards for the treatment of 
patients with depression is essential. Through the implementation of protocols, preceded by 
training and standard follow up, patients receive better quality care and have reduced utilization. 
Finally, patient education is an important aspect of treatment. Patients require time and attention 
when it comes to mental health concerns and proactively educating patients on the importance of 
good mental health as well as adhering to treatment regimens is essential. The below information 
details these themes and provides published articles and research that has laid the groundwork 
for much of the basis of this study. 
Collaborative Care Management 
Angstman et al. (2014) completed a retrospective cohort study where they reviewed 
7,430 patients with depression and just four were cared for in outpatient primary care sites. This 
study was conducted to understand whether having collaborative care management embedded in 
depression treatment would show better outcomes (Angstman et al., 2014). Through their 
analysis, they could prove that having collaborative care management within primary care is 
successful (Angstman et al., 2014). Results of the study indicated that the patients who were 
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enrolled in the collaborative care management program had better outcomes when compared to 
those who were not (Angstman et al., 2014). Thus, having an improvement in depression 
symptoms, they could relate this to decreased outpatient utilization for patients diagnosed with 
depression (Angstman et al., 2014).  
 Angstman, Rohrer & Rasmussen (2012) completed a retrospective chart review analysis 
where they reviewed 718 patients who were enrolled in collaborative care model. Patients with a 
diagnosis of depression were enrolled in the collaborative care model (CCM). These patients and 
their providers had the option to choose the CCM model or treatment as usual (Angstman, 
Rohrer & Rasmussen, 2012). Based on retrospective chart reviews in the data that was collected, 
those who had reached remission by 180 days after diagnosis were included in the study 
(Angstman, Rohrer & Rasmussen, 2012). At one month, there was a 40% remission rate 
(Angstman, Rohrer & Rasmussen, 2012). At five months, they were at a 70% remission rate, and 
the groups were in remission by six months by study design (Angstman, Rohrer & Rasmussen, 
2012).  
Results of this study suggest that clinical practice varies significantly regarding how often 
patients receive follow-up after a depression diagnosis (Angstman, Rohrer & Rasmussen, 2012). 
Early follow up is suggested to decrease the burden of the disease; however, follow up care does 
not require a physician. Screening can be completed by a nurse care manager, as in this case 
(Angstman, Rohrer & Rasmussen, 2012).  
Patient Health Questionnaire-9 
Ganguly et al. (2012) performed a random sampling of pediatrician administered PHQ-9 
questionnaires on patients between the ages of 14 and 18 with a clinical diagnosis of depression. 
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The reason for this study was to test the diagnostic accuracy of the PHQ-9 (Ganguly et al., 2012). 
233 patients in total were screened and they concluded that the PHQ-9 questionnaire, when 
compared to, the Beck Depression Inventory survey was psychometrically sound Ganguly et al., 
2012).  
Zimmerman (2013) completed a retrospective analysis on 5,458 patients who were 
randomly selected with a baseline of having a mental health disorder diagnosis. Zimmerman 
(2013) used scaled to monitor symptoms and treat depression (Zimmerman, 2013). He concluded 
that inconsistent scales were used to monitor treatment and that too many varieties of screening 
tools were available (Zimmerman, 2013). He recommended that there should be an alignment of 
screening tools to set one standard for better measurement of outcomes (Zimmerman, 2013). 
Clinical Standards for Treatment 
Loeb et al. (2014) explained that systematic approaches to depression identification and 
management are effective though not consistently implemented. The team created an algorithm 
for the care team to follow which was also embedded in their electronic medical record Loeb et 
al., 2014). The team completed a retrospective data analysis and found that attending training 
sessions were associated with an increase in documenting the PHQ-9 by 2.4 times (Loeb et al., 
2014). The research team implemented a depression protocol, preceded by training, in two 
faculty-resident practices. Medical assistants used the Patient Health Questionnaire (PHQ)-2 for 
initial screening; providers performed the PHQ-9. These were documented in the electronic 
medical record. 
Meunier et al. (2014) explained that depression remission and treatment decreases the 
number of visits to primary care. Successful treatment at six months reduced the likelihood of the 
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patient having more than eight visits during the six months following the original diagnosis of 
depression (Meunier et al., 2014). This study included a retrospective chart review analysis on 
1,733 primary care patients who were enrolled in collaborative care management and had six 
months follow up data (Meunier et al., 2014). They concluded that there is a decrease in 
outpatient utilization when a patient has successful remission at six months after the initial 
depression diagnosis (Meunier et al., 2014).  
O’Connor et al., (2009) completed an analysis of 33 articles on the benefits and harms of 
screening patients for depression in primary care settings. They concluded that without having 
systematic support within the primary care clinics, the depression outcomes would unlikely 
improve (O’Connor et al., 2009). Additionally, patients who have an initial diagnosis of 
depression should be carefully monitored, particularly those younger than 30 years old to ensure 
safety and optimal treatment (O’Connor et al., 2009).  
Olfson, Blanco & Marcus, 2016 completed a retrospective cohort study on 46,417 
responses to surveys in the United States households of patients 18 years of age or greater in 
2012 and 2013. Their efforts were to characterize the treatment of the above patient population 
(Olfson, Blanco & Marcus, 2016). 8.4% screen positive for depression, yet only 28.7% of that 
population received treatment (Olfson, Blanco & Marcus, 2016). If they had received treatment, 
studies suggest their remission scores would improve (Olfson, Blanco & Marcus, 2016). Lastly, 
they suggest that it is vital to strengthen the efforts to align depression care based on individual 
patient’s needs (Olfson, Blanco & Marcus, 2016).  
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Patient Education on Mental Health  
Reeves et al. (2011) completed a retrospective cohort study of data from CDC 
surveillance systems that measure the prevalence and impact of mental illness. From 2005 to 
2008, the CDC collected data showing that 6.8% of adults have moderate to severe depression 
and that depression prevalence is higher in southeastern states compared to other states (Reeves 
et al., 2011). They concluded that increasing awareness around the value of mental illness 
surveillance is essential, is increasing emphasis on public health actions and using monitoring to 
measure outcomes (Reeves et al., 2011). 
 Rohrer, Angstman & Pecina (2013) completed a case-control design study to demonstrate 
the feasibility of the method in a primary care practice setting and to understand why dropout 
patients chose not to follow up with the care provided to them. The study showed that dropout 
rates were more likely in geographic areas that had newer primary care sites, and that, 
established sites had a significantly lower drop-out rate (Rohrer, Angstman & Pecina, 2013). 
When implementing a program, it is crucial to address managerial problems in healthcare 
organizations (Rohrer, Angstman & Pecina, 2013).  
Accessibility of Mental Health Care 
Access is a significant issue when it comes to professional care for mental disorders 
(Costello et al., 2013). Less than half of adolescents with psychiatric disorders received any 
treatment (Costello et al., 2013). While access to care is challenging, social stigma continues to 
surround mental health disorders (Costello et al., 2013).  
In 2013, 10% of adolescents lacked insurance. Even in those that are covered, a number 
of mental health services they can receive is often limited (Mustangs, Garofalo, & Emerson, 
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2010). Initially identifying a mental health disorder is also challenging and routine screening is 
seldom done. In relation to children, mental health disorders are often times first recognized in 
school (Mustanski, Garofalo, & Emerson, 2010).  
There are several disparities documented by researchers. Those who are least likely to 
receive care are homeless or have been in child welfare and/or juvenile justice systems 
(Mustanski, Garofalo, & Emerson, 2010). Additionally, disparities exist in categories among 
those who are lesbian, gay, bisexual and/or transgender and of these groups, they are often the 
least likely to receive services (Mustanski, Garofalo, & Emerson, 2010).  
Care-Seeking Behaviors for Mental Health Disorders 
Models of behavior surrounding illness and care-seeking, such as Andersen’s (1995) and 
Mechanic’s (1962), accentuate the social and behavioral reinforcements of health decision 
making (Ojeda & Bergstresser, 2008). Andersen identifies health beliefs as an essential 
component of perceived need for health services and actual utilization (Ojeda & Bergstresser, 
2008).  
Health attitudes and values explain how social structure may influence resources, the 
need and the future use (Ojeda & Bergstresser, 2008). Since beliefs about health and the 
perceived need, are not sufficient to explain a person’s future behavior. Understanding health 
attitudes and valuces can help to understand the variation between the utilization of services 
across various groups (Ojeda & Bergstresser, 2008). 
This model of behavior and theory supports the concept that proactive screening will 
allow primary care physicians to find underlying depression symptoms that perhaps were not 
known to the patient. Many patients feel depressed but think that is a normal way of life, 
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especially those who are elderly. This type of mindset then puts the patient’s overall health at 
risk, as well as any comorbid conditions they have, leaving them with a diminished quality of life 
and susceptible to earlier death (Sharp & Lipsky, 2002). 
Mechanic (1962) identifies ‘illness behavior’ as a vital component of whether diagnosis 
and treatment will ever occur; this behavior is in part based upon whether the adoption of a ‘sick 
role’ is consistent with an individual’s social setting and position within the social group (Ojeda 
& Bergstresser, 2008). Shame and embarrassment is one deterrent to seeking care in mental 
health situations as is perceived loss of social status (Ojeda & Bergstresser, 2008).  
Gender also has implications for help-seeking (Ojeda & Bergstresser, 2008). Males and 
females seek out care for mental health care differently (Ojeda & Bergstresser, 2008). Stigma is 
considered a potential explanatory factor for the lower rate of mental health treatment among 
men; however little research has found the reasons why (Ojeda & Bergstresser, 2008).  
This theory has been shown to be consistent with the overall screening success rates 
between men and women. Many times, men will decline to be screened because of the stigma. 
Additionally, men are less likely to seek care for mental health problems because of the 
vulnerability that they must put themselves in.  
Many patients have a primary care provider whom they bond with and the patient and 
primary care provider have a trusted relationship. This relationship could help create a better 
atmosphere for the patient to be more likely to agree to screen for depression and expressing 
their feelings, therefore leading to better outcomes. This outcome could lead to better overall 
health as well as better results for any comorbid conditions they may have. 
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Assumptions 
There were assumptions made to this study, such as, missing data, which could occur in a 
completely random manner and thus their absence will not bias the study, even if a list wise or 
case wise data deletion technique will be used in data manager. Participants in this study told the 
interviewers the truth concerning the various variables for this study. Previous history of 
depression, when applicable, is in an area of the patient’s chart that can be pulled with the data 
set. Lastly, documentation of follow up is retrievable. Considering these assumptions enhances 
the validity of the study. 
Limitations 
The following limitations of this study are hereby acknowledged, this study relied on 
primary data analysis, thus some variables that may have added value to the study may not be in 
the dataset. Any data that was missed may affect the inferences drawn from this study and the 
researcher could not modify the dataset to ensure no missing data. Information bias resulting 
from varying levels of recall capacities of the respondents (whom have different levels of health 
literacy) may have negatively affected the findings of this study. Patients who were seen outside 
of the health system where the data will be pulled could be missing. 
Scope and Delimitations 
The data was collected from Geisinger’s electronic health record and only included 
depression screenings that were completed in one year’s time. The delimitations of this study 
included a retrospective study from electronic health records over a 5-year period. There were no 
control groups for comparison nor interventions for temporal analysis. The study was delimited 
to the variables present in the dataset selected for this study. 
25 
 
Potential for Positive Change 
In a national survey, 35% of people with severe depression symptoms reported that they 
had no care from a medical professional in the past year (Pratt & Brody, 2014). Routine follow 
up to care is essential in managing mental illness, specifically for depression (Pratt & Brody, 
2014). Mental illness is a burden on society and is the leading cause of disability across the 
world (World Health Organization, 2016). However, insufficient evidence is available about the 
type of follow-up care that may be most cost-effective.  
Depression alone accounts for 4.3% of the global burden of disease and is among the 
most significant single causes of disability worldwide, particularly for women (WHO, 2016). 
Depression also causes a significant burden on the economy (WHO, 2016). The total global 
impact of mental disorders is estimated to be $16.3 million between 2011 and 2030 (WHO, 
2016). By creating a systematic approach for routine screening for depression and a standard of 
care for primary care physicians, the significance that this disease has on health, comorbidity, 
and the economy could be drastically improved. Healthcare organizations could find benefit in 
the overall cost savings by decreasing utilization, particularly for overuse of emergency 
departments and inpatient services. Additionally, by creating a standard follow-up, patients will 
receive continuous follow up and utilizing outpatient services less, creating more access to 
primary care. 
The findings of the proposed study may be used to strengthen decision-making and 
policy guidelines, and the implementation of the following decisions and policies. Also, the 
results may fill the gap knowledge currently seen in factors hindering the effective and efficient 
utilization of available resources for the improvement of mental health screening and proper 
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follow up. There are several disparities documented by researchers. Of those who are least likely 
to receive care of those who are homeless or have been in child welfare and/or juvenile justice 
systems (Mustanski, Garofalo, & Emerson, 2010). Additionally, disparities exist in categories 
among those who are lesbian, gay, bisexual and/or transgender and of these groups, they are 
often the least likely to receive services (Mustanski, Garofalo, & Emerson, 2010).  
Knowledge gained from the findings could empower health workers with information for 
better health programming in primary care for mental health. Findings should service as baseline 
information for evidence-based health policies, especially in the management of depression. 
Results should be used for extensive bottleneck analysis of the mental health burden across the 
United States.  
Finally, education of both health workers and community members in the 
implementations of the findings may result in community empowerment and ownership and 
occasionally, community development and implementation of public programming. Furthermore, 
their involvement may help develop the need for access to more mental health providers. 
Summary and Conclusion  
Section 1 elaborately described the practice and benefits of screening for depression and 
the need for routine follow up in primary care settings. In addition, the purpose of the study, the 
nature of the study, the research questions and hypotheses, a detailed literature review with 
emphasis on limitations, delimitations and assumptions were given. The section ended with a 
description of the social change impact of the study. 
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Section 2 is focused on the methodology used for this inquiry. In this section, the 
population studied were described, the dataset used discussed, data management processes 
elaborated, and ethical issues and threats to validity explained. 
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Section 2: Research Design and Data Collection 
The purpose of this study seeks was to examine whether intervention with positive 
depression screening was related to improved overall depression symptoms. Depression places a 
tremendous burden on society, and determining a correlation between standard follow-up 
practices for those who screen positive could lead to standardization of treatment. This study 
focused on patients with a positive depression screening. The following covariates were 
evaluated for their effects on the relationship between positive depression screening and follow-
up care: baseline (initial) depression screening score, date of service, age, gender, consecutive 
depression screening score, date of consecutive depression screening, outcomes, and documented 
previous history of depression. This chapter includes a description of the study variables, 
covariates, research design, research questions and hypotheses, sampling procedures, instruments 
and constructs, sample size, data analysis plan, threats to validity, ethical considerations, and 
data management processes. 
Modeled Studies 
Angstman et al. (2014) completed a retrospective cohort study in which they reviewed 
7,430 patients with depression who were cared for in four outpatient primary care sites. This 
study was conducted to understand whether having collaborative care management embedded in 
depression treatment would show better outcomes, which could domenstrate that having 
collaborative care management within primary care is successful (Angstman et al., 2014). 
Findings showed that the patients who were enrolled in the collaborative care management 
program had better outcomes compared to those who were not (Angstman et al., 2014). 
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Collaborative care management was related to decreased outpatient utilization for patients 
diagnosed with depression (Angstman et al., 2014).  
 Angstman et al. (2012) completed a retrospective chart review analysis in which they 
reviewed 718 patients who were enrolled in a collaborative care program. Patients and/or 
providers had the option to choose the CCM model or treatment as usual (Angstman et al., 
2012). Based on retrospective chart reviews, those who had reached remission by 180 days after 
diagnosis were included in the study (Angstman et al., 2012). At 1 month, there was a 40% 
remission rate, and at 5 months there was at a 70% remission rate (Angstman et al., 2012). 
Care-Seeking Behaviors for Mental Health Disorders 
Models of behavior around illness and care seeking, such as Andersen’s (1995) and 
Mechanic’s (1962), emphasize the social and behavioral reinforcements of health decision-
making (Ojeda & Bergstresser, 2008). Andersen (as cited in Ojeda & Bergstresser, 2008) 
identified health beliefs as an important component of perceived need for health services and 
utilization. Health attitude and values explain how social structure may influence resources, 
need, and future use (Ojeda & Bergstresser, 2008). Because beliefs about health and the 
perceived need are not sufficient to explain a person’s future behavior, it can help understand the 
variation between utilization of services across various groups (Ojeda & Bergstresser, 2008). 
According to this model of behavior, proactive screening will allow primary care 
physicians to find underlying depression symptoms that perhaps were not known to the patient. 
Many patients feel depressed but think that is a normal way of life, especially those who are 
elderly. This mind-set then puts the patient’s overall health at risk, as well as any comorbid 
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conditions they have, leaving the person with a diminished quality of life and susceptible to 
premature death (Borowsky et al., 2000). 
Mechanic (1962) identified illness behavior as a crucial component of whether diagnosis 
and treatment will occur. This behavior is in part based on whether the adoption of a sick role is 
consistent with an individual’s social setting and position within a social group (Ojeda & 
Bergstresser, 2008). Shame and embarrassment is one deterrent to seeking care in mental health 
situations, as is perceived loss of social status (Ojeda & Bergstresser, 2008).  
Research Design and Rationale 
After receiving IRB approval (06-21-17-0344093) by Walden University, I extracted the 
raw data set from the study site. I used a retrospective cohort inquiry approach to collect the data 
followed by a retrospective quantitative study to analyze the data. The data set chosen for this 
research was available to me from Geisinger Health System. Geisinger agreed to allow me to use 
de-identified data from their electronic health record. Geisinger began screening patients for 
depression in 2012, using the PHQ-9 tool in their community medicine clinics which spans 
across northeastern and central Pennsylvania. This tool is used for patients age 18 and older, is 
available at each office visit, and is required once per year unless there is a previous score higher 
than 10. The data set has over 750,000 patients who completed the questionnaire, including their 
scores, interventions, and follow-up treatments. Based on my G Power analysis, I chose to have 
SPSS randomly choose 1,282 cases out of the original 15,784 available for the 2015 year. 
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Treatment was considered as having seen a professional mental health provider and whether the 
overall PHQ-9 score had decreased. 
The independent variable in this study was treatment. The selection criteria for this study 
included a positive depression score. Patients with a score of 10 or higher were categorized as 
having a positive depression screening, which required further intervention. The PHQ-9 was 
used in all outpatient primary care offices for patients 18 and older. The exclusion criteria for 
this sample were patients who were referred outside of the study site health system for 
professional mental health services. 
The dependent variable was symptom reduction. Covariates were initial date of visit, age, 
initial screening, gender, and location. Covariates were broken into groups so they could be 
measured appropriately. Patients who had previous treatment were also added. Multiple linear 
regression analysis was used to evaluate the relationship between positive depression screening 
and symptom reduction follow-up for these covariates.  
 Screening referred to a screening within a primary care outpatient visit. For patients who 
were seen more than once during the measurement period, each visit was considered a separate 
screening. The data included patients who were 18 years of age or older who had a completed 
office visit with a PHQ-9 score of 10 or higher within the calendar year 2015. Additional 
inclusion criteria were those who had a follow-up with either a professional mental health 
provider or their primary care provider, or anyone who had a previous history of depression 
dating back 5 years from 2015. The comparison group consisted of patients with a primary score 
of 10 or higher with subsequent office visits and another depression screening based on the 
criteria above. 
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Descriptive statistics were run for each variable; then two-way tables were run between 
the follow-up screening and each independent variable. A multivariable linear regression model 
was used to evaluate the relationship with intervention in the two-way tables, with depression 
screening results as the primary predictor. Results included analyses of relationships between the 
various covariates and intervention. Individuals who underwent intervention after their initial 
positive depression screening were compared to their original score to test the hypothesis that the 
patient with treatment had a more successful intervention.  
Methodology 
The methodology included the area/population, data management processes, sampling 
techniques, threats to validity, and ethical considerations. 
Population 
The target population consisted of outpatient primary care patients age 18 or over who 
were seen in 2015. The sample was taken from the total number of office visits that were 
completed using the PHQ-9 throughout 2015. 
Sampling and Sampling Procedures 
The sampling criteria included patients who had a completed office visit in a primary care 
office, completed a PHQ-9 in 2015, and were 18 years of age or older. Sample size was 
calculated using G*Power. Sample size analysis was carried out for the dependent variable of 
depression results, to give a power of 95%, and a 95% two-sided confidence interval. The 
minimum sample size was 1,282. 
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Procedures for Data Collection 
The study site nurse information officer gave permission to use the requested de-
identified data for research purposes. The data set included all patients who completed PHQ-9 
questionnaires, were age 18 or over at the time of visit during 2015, and completed primary care 
visit. For each case, I confirmed the date of office visit and completed PHQ-9 score. 
Additionally, I confirmed the patient’s age and gender at the time of the visit, the medical record 
number, the follow-up visit date with either a professional mental health provider or PCP, and 
the corresponding PHQ-9 results. The following were confirmed for the independent variable: 
referred to mental health professional, referred to treatment, and completion of treatment. The 
second variable included whether the primary care provider completed any of the following: 
medication therapy, education, or counseling. 
Instrumentation and Operationalization of Constructs 
The Patient Health Questionnaire was used as the foundation for an examination of 
depression as a syndrome (Zimmerman et al., 2008). The Patient Health Questionnaire is the 
recommended screening tool by the National Committee for Quality Assurance. The Patient 
Health Questionnaire is validated starting at 12 years of age (Zimmerman et al., 2008). 
Adolescents are required to complete the PHQ-9, modified for teens questionnaire (Zimmerman 
et al., 2008). 
Adult patients may be screened using the PHQ-2, which is a two-question screening tool 
(Zimmerman et al., 2008). If the patient completes the questionnaire and receives a total score of 
3 or higher, the patient is encouraged to complete the PHQ-9 for a recommended treatment plan 
(Zimmerman et al., 2008). This questionnaire is used to assess patients for depleted interest or 
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pleasure in doing things as well as feelings of depression or hopelessness. The results allow the 
clinical team to understand the patient’s level of depression while providing for the effectiveness 
of treatment (See Appendix A). Measurement is an overall score from the questions answered. A 
total score of 10 or higher signifies a positive screen, requiring a physician’s intervention to 
create a treatment plan. The depression score ranges are as follows: 5 to 9 (mild), 10 to 14 
(moderate), 15 to 19 (moderately severe), 20 or higher (severe). 
Screening Outcomes 
There are many reasons to measure outcomes for screening, including quality patient 
care, regression of symptoms, identification of new symptoms, and treatment adjustments. 
Studies showed that many patients are on an antidepressant for several months and are not seeing 
any benefits (Zimmerman et al., 2008). Regression of symptoms may occur after initial 
treatment; however, symptoms may not have significantly changed and therefore additional 
treatment or a change in treatment may be required (Zimmerman et al., 2008).  
Data Analysis Plan 
Data were reviewed for duplicate cases, clear inconsistences, and missing data to 
determine whether cases could be retained. Patients seen more than once in the data collection 
period were treated as separate screenings. Descriptive statistics were calculated on each 
variable, and data were examined to identify outliers or erroneous data. 
Research Questions and Hypotheses 
Research Question 1: Among patients who are screened as positive for depression, is 
symptom reduction more likely for those who receive treatment when controlling for age, 
gender, and number of previous episodes of depression? 
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H01: There is no statistically significant association between untreated and treated 
patients in symptom reduction when controlling for age, gender, and number of previous 
episodes of depression. 
Ha1: There is a statistically significant association between untreated and treated patients 
in symptom reduction when controlling for age, gender, and number of previous episodes of 
depression. 
The method of measurement was a difference score analysis, which involved subtracting 
the dependent variable (baseline score) from the follow-up score, followed by a multiple linear 
regression analysis for the independent variable and covariate. A t test, which was derived from 
multiple linear regression analysis, was used to compare mean depression screening change for 
patients who were treated. 
Research Question 2: Among patients who are screened as positive for depression, is 
symptom reduction more likely for those who complete a course of treatment from a mental 
health specialist in comparison to those who are treated by their primary care providers when 
controlling for age, gender, and number of previous episodes of depression? 
H02: There is no statistically significant association between symptom reduction and 
completing a course of treatment from a mental health specialist in comparison to not completing 
treatment when controlling for age, gender, and number of previous episodes of depression. 
Ha2: There is no statistically significant association between symptom reduction and 
completing a course of treatment from a mental health specialist in comparison to not completing 
treatment when controlling for age, gender, and number of previous episodes of depression. 
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The method of measurement was a difference score analysis, which involved subtracting 
the dependent variable (baseline score) from the follow-up score, followed by a multiple linear 
regression analysis for the independent variable and covariate. A t test, which was derived from 
multiple linear regression analysis, was used to compare mean depression screening change for 
patients who initially screened positive and were treated by a mental health specialist. 
Threats to Validity 
Threats to External Validity 
Each outpatient clinic has various workflows for rooming patients and capturing data, 
however, each clinic has a standard way to complete the screening. Physicians, physician’s 
assistants, certified registered nursing practitioners and mental health specialists all use their own 
clinical judgement and have their own approaches. Lastly, one commonality to all care providers 
is that they have a commitment to quality care and to improve outcomes for patients with a 
positive mental health evaluation.  
Threats to Internal Validity 
One potential threat to internal validity is the extent to which of my statistical test 
assumptions are met. 
Threats to Construct or Statistical Conclusion Validity 
Threats to construct or statistical conclusion validity in this study may be found in 
potential selection bias, in that patients who are found to receive intervention could be of those 
who are deemed at higher risk or are more willing to intervention. 
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Summary and Conclusions 
Section 2 included a description of the study variables, covariates, research design, 
research questions and hypothesis, sampling procedures, explanation of instruments and 
constructs used, determinations of sample size, a data analysis plan, report of threats to validity, 
ethical considerations, and data management processes. 
The results of this study are in pursuit to provide further insight into whether intervention 
with positive depression screening is related to overall improved depression symptoms. As 
previously defined, mental health problems are a tremendous burden on society, and by 
understanding, there is a relationship between standard follow up for those who screen positive 
could lead to standardization of treatment. Hence, this research is designed to fill a gap in 
understanding by focusing specifically on the outcomes of treatment for those patients who have 
a positive depression screening (Pratty & Brody, 2014). 
The results of this study focused on patients with a positive depression screening, because 
of the burden undiagnosed depression can cause. The following covariates were evaluated for 
their effects on the relationship between positive depression screening and follow up care: 
baseline (initial) depression screening score, date of service, age, gender, consecutive depression 
screening score, date of consecutive depression screening, outcomes and documented previous 
history of depression, when applicable. In Section 3, methodology, and procedures for the data 
collection and findings are reviewed. 
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Section 3: Presentation of the Results and Findings 
The purpose of this study was to determine whether remission of depression symptoms 
was associated with recommended follow-up care. This project was unique because it addressed 
the problem of depression and proposed a way in which primary care can play a role in screening 
and managing patients with depression. The results may be used to understand the vital role of 
primary care physicians in mental health. Through creation of a systematic approach for routine 
depression screening and a standard of care for primary care physicians, health, comorbidity, and 
the economy could be improved. In this section I describe the data collection, descriptive and 
demographic characteristics, data analysis, and results. The following hypotheses were used to 
guide the study: 
H01: There is no statistically significant association between untreated and treated 
patients in symptom reduction when controlling for age, gender, and number of previous 
episodes of depression. 
Ha1: There is a statistically significant association between untreated and treated patients 
in symptom reduction when controlling for age, gender, and number of previous episodes of 
depression. 
H02: There is no statistically significant association between symptom reduction and 
completing a course of treatment from a mental health specialist in comparison to not completing 
treatment when controlling for age, gender, and number of previous episodes of depression. 
Ha2: There is no statistically significant association between symptom reduction and 
completing a course of treatment from a mental health specialist in comparison to not completing 
treatment when controlling for age, gender, and number of previous episodes of depression. 
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Before describing the findings of this study related to the research questions, I explain 
how the data were handled including the data translation process, why data were discarded, data 
cleaning and preparation, and data organization. 
Data Handling 
Data Transfer, Translation, Cleaning, Coding, and Organizing 
Data transfer. After receiving IRB approval (06-21-17-0344093) by Walden University, I 
extracted the raw data set from the study site and saved it to my personal laptop, which is 
password protected. 
Data translation. I transferred the data from the original file to an Excel spreadsheet and 
formatted the data appropriately. Once the data were cleaned and organized, I imported them to 
SPSS for statistical analysis. 
Data cleaning and discarding. Data transferred from the study site were received 
without any patient identification. The file was saved with only medical record numbers, location 
of the completed questionnaire, demographic information, and questionnaire results. No data 
were missing for any case. The original G* Power analysis suggested 1,282 cases. Out of the 
1,282 cases obtained, there were 36 duplicate records. This resulted in a final data set of 1,246 
cases. 
Data Coding and Recoding 
Dependent variable coding and recoding. Although only one dependent variable 
(difference score) was considered for this study, it was subjected to a two-step coding process. 
The first coding process included a dichotomic variable for correlation and linear regression 
analysis. The difference score resulted in a new variable that resulted from subtracting the 
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follow-up PHQ-9 score from the original PHQ-9 score. This coding process was designed to 
determine whether the patient had a positive or negative response to the initial intervention. 
Patients who either declined or did not have a follow-up response value were considered 
dropouts. The dropout variable was created based on a result in the follow-up response field of 
patient declined or no follow-up was detected in the variable category. 
 Independent variable coding and recoding. The data set comprised a 10 independent 
variables (IVs) that included three demographic variables of age, gender, and county. These 
variables were used in descriptive statistical analysis and in correlation analysis. Age was 
categorized using the following groups: 18-29, 30-45, 46-55, 56-64, 65-74, and 75-101. Gender 
was coded as a bivariate with 0 assigned to men and 1 to women. County was coded 
categorically based on the county where the questionnaire was completed. Month was also used 
as an IV and coded categorically as well.  
 A total of six outcome variables were used as IVs: previous treatment, no change in 
follow-up by mental health, no change in follow-up by primary care provider (PCP), patient 
declined treatment, PCP initiated a medication change, and patient was referred by PCP to a 
community mental health provider. Each of these variables were originally coded by a manual 
chart review as yes or no based on the outcome of the follow-up response. When a patient had a 
positive PHQ-9, the provider had the responsibility of indicating what the intervention would be. 
In each case, the patient was put into one of the six outcome interventions. Each variable was 
then recoded using dichotomized variables; each no was assigned a 0, and each yes was assigned 
a 1. After completing the data cleaning, coding, recoding, and organizing, I calculated the mean, 
standard deviation, and p values for demographic data and the six outcome variables.  
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Description of the Variables 
 The results are presented in four sections with each section addressing a depression 
category and as an overall population set. The first section presents results for demographics, and 
the second section presents results for statistical analyses.  
Age 
Although the mean age for the study sample was 45 years, the screening was conducted 
on a wide range of patients, with the youngest being 19 and the oldest being 101. Patients were 
broken down into categories of ages: 18-29, 30-45, 46-55, 56-64, 65-74, and 75101 (see Table 
2). Patients in the age groups between 18 and 64 were found not to be of statistical significance 
(p < .05); therefore the null hypothesis was affirmed. However, the patients in the age category 
of 75-101 had a p value of .047, (p < .05); therefore, the null hypothesis was rejected.  
Table 2 
 
Frequency Distribution of Demographic Variables Among Study Subjects (N=1,246) 
 
Variable                                                                     Frequency                                                   % 
Age (N=1,246) 
  18-29                                                                       266                                                              21.3% 
  30-45                                                                       379                                                              30.4% 
  46-55                                                                       272                                                              21.8% 
  56-64                                                                       164                                                              13.2% 
  65-74                                                                       109                                                                8.7% 
  75-101                                                                      50                                                                 4.5% 
 
Gender 
Table 3 shows that women composed a larger portion of the sample with a total of 882 
(71%). However, gender had a p value of .178, so the null hypothesis was affirmed. 
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Table 3 
 
 
Frequency Distribution of Demographic Variables Among Study Subjects (N=1,246) 
 
Variable Frequency % 
   
Gender (N=1,246) 
 
  
    Male (% of patients) 364 29.2% 
    Female (% of patients) 882 70.8% 
 
County 
Table 4 shows the distribution of results based on the county in which the patient 
completed the PHQ-9 questionnaire. Although the sample was intended to be dispersed evenly, 
there were areas in the data set that had higher patient percentages than others. Mifflin county 
had the largest portion with 228 patients (18.3%). Juniata and Clinton counties were second with 
12 patients (1%) and 23 (1.8%) patients. County showed no statistical significance to the model 
and therefore was not included in the regression model. 
43 
 
Table 4 
 
Frequency Distribution of Demographic Variables Among Study Subjects (N=1,246) 
Variable Frequency % 
County (N=1,246) 
  Adams       
  Centre  
  Clinton 
  Columbia 
  Juniata 
  Lackawanna 
  Luzerne 
  Lycoming 
  Mifflin 
  Northumberland 
  Schuylkill 
  Snyder 
  Union 
  Wyoming 
 
25 
114 
23 
203 
12 
18 
134 
103 
228 
49 
170 
60 
69 
38 
 
2% 
9.1% 
1.8% 
16.3% 
1% 
1.4% 
10.8% 
8.3% 
18.3% 
3.9% 
13.6% 
4.8% 
5.5% 
3.0% 
 
Month 
The time of year was taken into consideration in the statistical analysis. The distribution 
of completed PHQ-9 questionnaires were well dispersed throughout the data set (see Table 5). 
The months of January, February, March, April, October, November, and December showed a 
statistical significance (p < .05).  
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Table 5 
 
Frequency Distribution of Demographic Variables Among Study Subjects (N=1,246) 
Variable Frequency % 
Month (N = 1,246) 
  January 
  February 
  March 
  April 
  May  
  June 
  July 
  August  
  September 
  October 
  November 
  December 
 
80 
119 
131 
104 
100 
119 
129 
120 
94 
105 
71 
74 
 
6.4% 
9.6% 
10.5% 
8.3% 
8% 
9.6% 
10.4% 
9.6% 
7.5% 
8.4% 
5.7% 
5.9% 
 
Table 6 shows that the initial mean score for the PHQ-9 was 16 and the minimum was 10 
and maximum score was 27. Each total was categorized by severity based on the PHQ-9 severity 
definition. Most patients reported moderate depression (41.7%), which was a total score between 
10 and 14. The next largest group was moderate/severe depression (35.3%) with a total score 
between 15 and 19. 
 The follow-up responses had a mean of 9, 7 points lower than the initial score. The 
minimum was 0 and the maximum was 27. The follow-up results were categorized by depression 
severity, which is defined by the PHQ-9 questionnaire. The results showed that 30% of patients 
declined the follow-up questionnaire, 17% scored negatively with a total score of 0 to 4, and 
15.7% had no follow-up recorded. Out of the 673 patients who completed a follow-up, 78.5% 
were already under treatment. Only 1.8% of those patients declined treatment, and 38.4% had a 
medication change by their primary care provider at the follow-up visit. 
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Table 6 
 
Descriptive Statistics – Clinical Information – PHQ-9 (N=1,246) 
 
Variable  Frequency % 
PHQ-9 Initial Score (N=1,246)   
    Mean 16.08  
    Median 15.00  
    Std. Deviation 4.356  
    Range 17  
    Minimum 10  
    Maximum 27  
PHQ9 Initial Total: Depression Severity (N=1,246)   
Moderate Depression 
10-14 
520 41.7% 
Moderate/Severe Depression 
15-19 
440 35.3% 
Severe Depression 
20-27     
286 22.9% 
 
PHQ9 Follow Up Response (N=673) 
  
Mean 9.40  
Std. Deviation 7.419  
Minimum 0  
Maximum 27  
PHQ-9 Follow Up Response Value: By Category (N=1,246)   
Patient Declined 378 30.3% 
No Follow Up 195 15.7% 
Minimum/None (0-4) 213 17% 
Mild Depression (5-9) 156 12.5% 
Moderate Depression (10-14) 128 10.3% 
Moderately/Severe Depression (15-19) 98 7.9% 
Severe Depression (20-27) 78 6.3% 
Interventions:    
Previous Treatment   
Yes 979 78.5% 
No 276 21.4% 
PCP Initiated Medicaiton Change   
Yes 475 38.2% 
No 771 61.9% 
Referred to Community Mental Health   
Yes 225 18.1% 
No 1,021 81.9% 
Referred to Specialty Inpatient Psychiatry   
Yes 0 0% 
No 0 0% 
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Table 7 shows that 99.4% of patients received their initial PHQ-9 by their primary care 
provider, 99.6% received their follow up by their primary care provider as well. Using difference 
score analysis which would subtract the dependent variable of baseline follow, then using a 
multiple linear regression analysis for the independent variable and covariant. T-test derived 
from multiple linear regression analysis to compare mean depression screening change for 
patients who initially screen positive and were treated by a mental health specialist. 
Table 7 
 
Descriptive Statistics – Initial Screening & Follow Up Screening (N=1,246) 
Variable Frequency 
 
% 
Initial PHQ 2_9 Questionnaire (N=1,246)   
Primary Care Provider 
Mental Health Provider 
 
 
1,238 
    8 
 
99.4% 
 0.6% 
Follow Up PHQ 2_9 Questionnaire (N=1,246) 
Primary Care Office 
Mental Health Provider Office 
 
1,241 
    5 
 
99.6% 
 0.4% 
 
 
 Table 8 is the descriptive statistics for the difference score. The difference score was used 
as the dependent variable which was computed by taking the patients original (initial) score and 
subtracting it against the follow up score. Taking in account for patients who refused their follow 
up screening as well as those who did not have a follow up documented were part of the drop out 
criteria. The total number of patients, out of the original number, accounted for 750 patients 
where a difference score could be computed. 
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Table 8 
 
Descriptive Statistics – Difference Score (N=750) 
Difference (N = 750)   
Minimum      -16.0      
Maximum      27  
Mean        6.009 
SD       7.3489 
95% Confidence Interval of the Difference 
Lower       5.483 
Upper       6.536 
 
 
Two-Way Tests 
Table 9 is showing the various age categories that were in the total number of difference 
score output. Each age category was run through ANOVA to total number, mean and standard 
deviation. A statistically significant value, is one that is p < .05. In the noted ANOVA below, the 
age ranges from 65 through 101. The age group of 65-74 had a p = .110 and the age group of 
those 75-101 had a p = .100. Therefore, we can reject the null hypothesis that age does not have a 
correlation with depression. 
Table 9 
 
ANOVA – Dependent Variable (Difference Score Compared to Age Category) (N=750, 
p=0.027) 
Age Group N Mean Std. Deviation 
18-29 165 6.624 8.14080 
30-45 209 7.110 7.3591 
46-55 136 5.985 7.4565 
56-64 80 6.563 6.6004 
65-74 58 6.500 7.0344 
75-101 25 8.480 7.2521 
 
 
Table 10 is showing gender compared to the total number of difference score output. 
Females were dominant in this number with a total of 475, whereas only 198 males were 
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represented. They both had a p value <.05, therefore, we can reject the null hypothesis that 
gender does not have a correlation with depression. 
Table 10 
 
ANOVA – Dependent Variable (Difference Score Compared to Gender) (N=750, p=0.217) 
Gender N Mean Std. Deviation 
Male 198 6.146 7.7978 
Female 475 6.926 7.3042 
 
 
 Each of the independent variables were then ran through ANOVA separately to compare 
the variable to the difference score (DV). (Table 9-18). 
Table 11 is showing the month that the survey was completed compared to the total 
number of difference score output. The months were fairly distributed with January through 
April and October through December. 
Table 11 
 
ANOVA – Dependent Variable (Difference Score Compared to Month) (N=673, p=.342) 
Month Mean N Std. Deviation 
January 7.356 45 8.4750 
February  5.453 75 6.7949 
March 8.944 71 7.2740 
April 6.085 59 7.8768 
May 6.404 47 6.9522 
June 6.636 66 7.6934 
July 7.235 68 7.8534 
August 6.880 50 7.1504 
September 6.958 48 7.5652 
October 5.193 57 7.5603 
November 6.233 43 6.8966 
December 6.818 44 7.1407 
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Table 12 shows that the difference score compared to a patient being previously treated, 
has a larger number of those patients treated with 548 patients out of the 673 total. 
Table 12 
 
ANOVA – Dependent Variable (Difference Score Compared to Previous Treatment) (N=673, 
p=.188) 
Previous Treatment for Depression N Mean Std. Deviation 
No 125 5.904 7.3281 
Yes 548 6.878 7.4790 
 
 Table 13 shows that the difference score compared to a patient who has no change in 
therapy by their mental health provider a larger number of those patients did not have a change 
in treatment by their mental health provider. 
Table 13 
 
ANOVA – Dependent Variable (Difference Score Compared to No Change in Treamtnet by 
Mental Health) (N=673, p=.450) 
No Change in Treatment by Mental Health Provider N Mean Std. Deviation 
Yes 
No 
57 
616 
5.982 
6.763 
8.1580 
7.3908 
 
 
 Table 14 shows that the difference score compared to a patient who has no change in 
therapy by primary care provider (pcp) a larger number of those patients did not have a change in 
treatment by primary care provider (pcp). 
Table 14 
 
ANOVA – Dependent Variable (Difference Score Compared to No Change In Treatment by 
PCP) (N=673, p=0.45) 
No Change in Treatment by Primary Care Provider (PCP) N Mean Std. Deviation 
Yes 
No 
143 
530 
5.587 
6.996 
7.0853 
7.5307 
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 Table 15 shows that the difference score compared to those patients who declined follow 
up treatment, of the 673-total number of patients, only 9 declined treatment. 
Table 15 
 
ANOVA – Dependent Variable (Difference Score Compared to Patient Declined) (N=673, 
p=.744) 
Patient Declined Follow Up N Mean Std. Deviation 
Yes 
No 
  9 
664 
5.889 
6.708 
6.9001 
7.4669 
 
 Table 16 shows that the difference score compared to patients who had a medication 
adjustment and/or change by their primary care provider (pcp), 277 of the 673-total number of 
patients had a medication adjustment and/or change due to the results of the depression 
screening. 
Table 16 
 
ANOVA – Dependent Variable (Difference Score Compared to PCP Medication Change) 
(N=673, p=.000) 
PCP Changed Medication N Mean Std. Deviation 
Yes 
No 
277 
396 
8.206 
5.641 
7.5827 
7.1884 
  
Table 17 shows that the difference score compared to patients who were referred to their 
community mental health provider. Only 127 out of the 673-total number of patients were 
referred to a community mental health provider. 
Table 17 
 
ANOVA – Dependent Variable (Difference Score Compared to Referred to Community Mental 
Health Provider (N=673, p=.005) 
Patient was referred to a Mental Health Provider N Mean Std. Deviation 
Yes 
No 
127 
546 
8.370 
6.308 
8.0077 
7.2737 
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 Table 18 shows that the difference score compared to patients who were referred to 
inpatient psychiatry care. Out of the entire sample of patients, no patient was referred to inpatient 
psychiatric care based on their depression screening. 
Table 18 
 
ANOVA – Dependent Variable (Difference Score Compared to Referred to Inpatient 
Psychiatry (N=673) 
Patient was referred to Inpatient Psychiatry N Mean Std. Deviation 
Yes 
No 
  0 
673 
 
6.697 
 
7.4554 
 
 The below table (Table 19) shows the multiple linear regression analysis for each 
independent variable (IV) and the difference score (DV). With that said, two significant 
independent variables were PCP initiated medication change (b=2.5, p<0.01), and referral to 
community health (b=1.6, p=0.037) indicating successful intervention. When the PCP initiates 
change in medication the depression score shows improvement by 2.5. Referral for patients to 
community health produces a 1.6 decrease to the depression score. The clinical interventions of 
initiating medication changes and referral to community health show benefit to the patient.  
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Table 19 
 
Multiple Linear Regression for the Difference Score and Independent Variables 
 
 
Unstandardized 
B 
Coefficients 
Std. Error 
Standardized 
Coefficients Beta 
t Sig. 95% Confidence 
Interval for B 
      Lower 
Bound 
Upper 
Bound 
(Constant) 4.003 .986  4.062 .000 2.068 5.939  
 
Gender 
 
.852 
 
.632 
 
.052 
 
1.349 
 
.178 
 
-.388 
 
2.093 
 
Previous Treatment  
.202 
 
.768 
 
.011 
 
.263 
 
.793 
 
-1.306 
 
1.709 
 
No Change in 
Treatment: Treated 
by Mental Health 
 
 
 
.257 
 
 
 
 
 
1.079 
 
 
 
 
 
.010 
 
 
 
 
 
.238 
 
 
 
 
 
.812 
 
 
 
 
 
-1.861 
 
 
 
 
 
2.375 
 
PCP Initiated 
Medication Change 
 
 
 
2.495 
 
 
 
.632 
 
 
 
.165 
 
 
 
3.950 
 
 
 
.000 
 
 
 
1.255 
 
 
 
3.735 
 
Referred to 
Community Mental 
Health 
 
 
 
1.564 
 
 
 
.748 
 
 
 
.082 
 
 
2.091 
 
 
 
.037 
 
 
 
.095 
 
 
 
3.032 
 
Age Group: 30-45  
.941 
 
.773 
 
.058 
 
1.217 
 
.224 
 
-.577 
 
2.459 
 
Age Group: 46-55  
.013 
 
.867 
 
.001 
 
.015 
 
.988 
 
-1.689 
 
1.715 
 
Age Group: 56-64  
.939 
 
1.021 
 
.041 
 
.920 
 
.358 
 
-1.065 
 
2.943 
 
Age Group: 65-74  
.688 
 
1.133 
 
.026 
 
.607 
 
.544 
 
-1.537 
 
2.914 
 
Age Group: 75-101  
3.187 
 
1.599 
 
.081 
 
1.994 
 
.047 
 
.048 
 
6.326 
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Dropout Analysis 
The dropout analysis was interpreted to see if they are different from people who had 
follow up data on because if they are different then your fingings might be biased. Table 20 – 22 
show a cross tabulation between the dropout variable compared to each of the independent 
variables in order to show the frequencies for each. The age group between 56-74 had over 50% 
patients drop out, meaning they declined treatment or did not have a documented follow up. This 
is true also for the age group of 75-101. When compared to gender, the dropout rate was 
interestingly the same for both males and females. Patients who have had been previously treated 
for depression (44%) had a lower drop out rate than those without any documentation of 
previous treatment (53.4%). 
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Table 20 
 
Cross Tabulation: Dropout Compared to Age (N=1,246, p=0.027) 
   Dropout  
   No Yes       Total 
Age 
Group 
18-29 Count 165 101 266 
  
 
 
% within Age Group 
 
62% 
 
38% 
 
100% 
 30-45 Count 209 170 379 
   
% within Age Group 
 
55.1% 
 
44.9% 
 
100% 
 46-55 Count 136 136 272 
   
% within Age Group 
 
50% 
 
50% 
 
100% 
 56-64 Count 80 84 164 
   
% within Age Group 
 
48.8% 
 
51.2% 
 
100% 
 65-74 Count 58 51 109 
   
% within Age Group 
 
53.2% 
 
46.8% 
 
100% 
 75-101 Count 25 31 56 
   
% within Age Group 
 
44.6% 
 
55.4% 
 
100% 
Total  Count 673 573 1,246 
   
% within Age Group 
 
54% 
 
46% 
 
100% 
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Table 21 
 
Cross Tabulation: Dropout Compared to Gender (N=1,246, p=0.217) 
     Dropout  
   No Yes       Total 
Gender Male Count 198 166 364 
  
 
 
% within Age Group 
 
54.4% 
 
45.6% 
 
100% 
  
Female 
 
Count 
 
475 
 
407 
 
882 
   
% within Age Group 
 
53.9% 
 
46.1% 
 
100% 
 
Total 
  
Count 
 
673 
 
573 
 
1,246 
   
% within Age Group 
 
54% 
 
46% 
 
100% 
 
Table 22 
 
Cross Tabulation: Dropout Compared to Previous Treatment (N=1,246, p=.188) 
     Dropout  
   No Yes       
Total 
Previous Treatment No Count 125 142 267 
  
 
 
% within Previous 
Treatment 
 
46.8% 
 
53.2% 
 
100% 
  
Yes 
 
Count 
 
548 
 
431 
 
979 
   
% within Previous 
Treatment 
 
56% 
 
44% 
 
100% 
      
Total  Count 673 573 1,246 
  % within Previous 
Treatment 
54% 46% 100% 
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Summary 
Results failed to reject H1A, there is a statistically significant association between 
untreated and treated patients in symptom reduction when controlling for age, gender and 
number of previous episodes of depression. There were no correlations between patient’s gender, 
however age did play a significant factor. The p value shows the probability of finding the 
observed results when the null hypothesis of the study questions is true.  
 The results also supported the second research question, H2A that there is statistically 
significant association between completing a course of treatment from a mental health specialist 
and symptom reduction in comparison to not completing treatment when controlling for age, 
gender and number of previous episodes of depression. Referral for patients to community health 
produces a 1.6 decrease to the depression score. The clinical interventions of initiating 
medication changes and referral to community health show benefit to the patient. The results 
supported that treatment by the patient’s primary care provider (pcp) has more benefit than 
mental health treatment, though both led to significant improvement.  
Table 19, above, showed the multiple linear regression analysis for each independent 
variable (IV) and the difference score (DV). When controlling for the other independent 
variables, two significant independent variables were PCP initiated medication change (b=2.5, 
p<0.01), and referral to community health (b=1.6, p=0.037) indicating successful intervention. 
When the PCP initiates change in medication the depression score shows improvement by 2.5. 
Referral for patients to community health produces a 1.6 decrease to the depression score. The 
clinical interventions of initiating medication changes and referral to community health show 
benefit to the patient.  
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Depression impacts the well-being of patients. As described previously, mental health is a 
tremendous burden on society and by understanding if there is a correlation between standard 
follow up for those who screen positive could lead to standardization of treatment. Hence, this 
research is designed to fill a gap in understanding by focusing specifically on the outcomes of 
treatment after testing positive during depression screening (Pratt & Brody, 2014). 
Section 4 will include information on the implications to change and ways to apply these 
findings into practice. Through the findings in this study I plan to provide further insight into 
whether intervention with positive depression screening is related to overall improved depression 
symptoms in the next section. 
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Section 4: Application to Professional Practice and Implications for Social Change  
 The goal of this project was to study patients who completed routine depression 
screenings in their primary care office. Patients who had a total score of 10 or higher on the 
depression screen were followed to determine whether their difference score showed any 
correlation with follow-up care when controlling for age, gender, and previous treatment. The 
expected follow-up for patients who had a positive screening was with their primary care 
physician or mental health counselor. Findings indicated that routine depression screening is 
important and that follow-up care is essential and successful. 
Findings and Implications 
A sample of 1,246 out of 15,784 cases was randomly chosen using SPSS software. 
Descriptive analyses, ANOVAs, multiple linear regression, and cross tabulations were conducted 
to analyze the data. A patient who completed a PHQ-9 and scored a total of 10 or higher was 
included in the data set (see Appendix A). 
Results indicated a statistically significant association between untreated and treated 
patients in symptom reduction when controlling for age, gender, and number of previous 
episodes of depression. There was no correlation between patient’s gender; however, age did 
play a significant factor. Results also indicated a statistically significant association between 
symptom reduction and completing a course of treatment from a mental health specialist when 
controlling for age, gender, and number of previous episodes of depression.  
Results from multiple linear regression analysis indicated that PCP-initiated medication 
change and referral to community health were significantly associated with successful 
intervention when controlling for other independent variables. When the PCP initiated change in 
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medication, the depression score improvement by 2.5 points. Referral for patients to community 
health produced a 1.6 point decrease in the depression score. The clinical interventions of 
initiating medication changes and referral to community health were beneficial to patients. 
Recommendations 
 Based on the results of this project, recommended practice guidelines for primary care 
providers include proactive, routine depression screening for all patients 18 years and older. 
Continuing education is recommended for clinical staff to address the burden of mental health, 
health diseases, signs, symptoms, and the appropriate ways to treat patients. Protocols for follow-
up standardized treatment should be implemented to ensure that patients are not lost in follow-
up. Implementation of recommendations should follow standards of care proposed by the 
American Academy of Psychology for primary care providers on how to successfully manage 
patients who are being treated for mental health disorders. 
Recommendations for Future Research 
Expanded research should be conducted on the correlation between routine screening and 
treatment outcomes, and whether screening is an effective way to identify patients with 
underlying mental health problems. Findings may be used to close the gap in care with patients 
who decline further depression screenings. Researchers could also examine ways to close the gap 
in care with patients who are lost to follow-up, including creating registries dedicated to patients 
with defined depression and ensuring they are being managed. This could be part of the 
collaborative care management process discussed in Section 1. 
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Strengths and Limitations 
 One of the strengths of this project was the robust literature review that identified the 
need for further research on the prevalence of depression screening in the primary care setting. 
Another strength was providing support for routine screening of patients for depression in the 
primary care setting using PHQ-9. The findings in this study further demonstrated the reliability 
and validity of the PHQ-9 depression screening tool. 
 The first limitation to this study was that the study only included 12 months of follow-up 
data; patients who had a follow-up after the 12-month data capture were missed. Another 
limitation was the literacy level of the patients who were randomly chosen. Lastly, using data 
from a system that has 50+ outpatient primary care settings could have resulted in accidental 
exclusion of patients who were offered a follow-up screening. Educating the clinical support 
staff and physicians on the importance of screening all patients for depression at every visit may 
decrease the number of patients who are lost to follow-up. 
Dissemination Plan 
 I will share findings with my colleagues and partners at the study site to emphaize the 
need for change in the way depression is viewed in the outpatient setting. I plan to disseminate 
findings to local health care leaders with the intention to expose gaps in follow-up care and to 
hold clinical staff accountable for completing necessary screening. The plan for external 
dissemination includes presenting findings to other health care organizations and providers to 
raise awareness of successful routine screenings. Routine screening is essential for identifying 
patients who are not exhibiting symptoms. One of the significant obstacles to overcome with this 
issue is to ensure that the clinicians and clinical support staff are well versed on this subject and 
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understand the necessary protocols for follow-up treatment. It is unethical for practicing 
physicians and staff members to continue losing patients to follow-up without an action plan to 
help close this care gap. Findings from this project may be used to encourage health care 
providers to proactively screen patients for depression and create a follow-up protocol to ensure 
the patient is receiving the proper intervention to yield positive results.  
Social Change Implications 
Routine screening is essential for identifying patients who are not exhibiting symptoms. 
In January 2016, the USPSTF recommended screening for depression in all adults (Siu & 
USPSTF, 2016). Their recommendation was to screen patients before they present with 
depression-like symptoms while using a validated screening tool (Siu & USPSTF, 2016). The 
USPSTF also recommended that accurate diagnosis, plan of care, and routine follow-up be put in 
place for the treatment to be effective (Siu & USPSTF, 2016).  
Depression is one of the leading causes of disability in the United States, and screening is 
beneficial in the detection of depression (Siu & USPSTF, 2016). Depression can create 
difficulties at work and in people’s personal lives (Siu USPSTF, 2016). However, screening is 
just the beginning. Follow-up care is a crucial element in ensuring that patients receive effective 
care. According to Olfson et al. (2016), 72% of patients who screen positive for depression are 
not getting the follow-up care required to effectively manage and/or treat their mental illness. 
One of the significant obstacles to overcome is to ensure that the clinicians and clinical 
support staff are educated on the prevalence of mental health disorders. Nearly 60% of adults 
with a diagnosed mental illness have not sought care in the previous year (National Alliance on 
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Mental Illness [NAMI], 2014). It is unethical for practicing physicians and staff members to 
continue losing patients to follow-up without an action plan to close this care gap.  
Mental health is one of the costliest diseases in the United States, and each year $193 
billion is spent on mental health (NAMI, 2014). Findings from the current study were 
statistically significant for two of the 10 independent variables including PCP-initiated 
medication change and referral to community health. Findings showed that when the PCP 
initiated change in medication, the depression score improved by 2.5 points. Referral of patients 
to community health produced a 1.6 point decrease in the depression score. The clinical 
interventions of initiating medication changes and referral to community health show benefits to 
patients. Standardizing follow-up protocols for clinicians is an important aspect of successful 
intervention. Depression is the primary cause for disability worldwide and is the major 
contributor to global disease burden (NAMI, 2014). Findings from this study may be used to 
educate clinicians and nurses on the importance of routine depression screening. The 43.8 
million adults who experience mental illness each year deserve higher quality care (NAMI, 
2014). 
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Appendix A: Patient Health Questionnaire – 9 (PHQ-9) 
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Appendix C: Data Usage Agreement 
 
DATA USE AGREEMENT 
 
 
This Data Use Agreement (“Agreement”), effective as of May 6, 2017 (“Effective 
Date”), is entered into by and between Juli Molecavage (“Data Recipient”) and Geisinger 
Health System (“Data Provider”). The purpose of this Agreement is to provide Data Recipient 
with access to a Limited Data Set (“LDS”) for use in research in accord with the HIPAA and 
FERPA Regulations.  
 
1. Definitions. Unless otherwise specified in this Agreement, all capitalized terms used in this 
Agreement not otherwise defined have the meaning established for purposes of the 
“HIPAA Regulations” codified at Title 45 parts 160 through 164 of the United States 
Code of Federal Regulations, as amended from time to time. 
2. Preparation of the LDS. Data Provider shall prepare and furnish to Data Recipient a LDS in 
accord with any applicable HIPAA or FERPA Regulations  
Data Fields in the LDS. No direct identifiers such as names may be included in the Limited 
Data Set (LDS). The researcher will also not name the organization in the doctoral project report 
that is published in Proquest. In preparing the LDS, Data Provider or shall include the data fields 
specified as follows, which are the minimum necessary to accomplish the research: PHQ 2_9 
overall score, date of completion, patient gender, patient age, site in which the 
questionnaire was completed. 
3. Responsibilities of Data Recipient. Data Recipient agrees to: 
a. Use or disclose the LDS only as permitted by this Agreement or as required by 
law; 
b. Use appropriate safeguards to prevent use or disclosure of the LDS other than as 
permitted by this Agreement or required by law; 
c. Report to Data Provider any use or disclosure of the LDS of which it becomes 
aware that is not permitted by this Agreement or required by law; 
d. Require any of its subcontractors or agents that receive or have access to the LDS 
to agree to the same restrictions and conditions on the use and/or disclosure of the 
LDS that apply to Data Recipient under this Agreement; and 
e. Not use the information in the LDS to identify or contact the individuals who are 
data subjects.  
4. Permitted Uses and Disclosures of the LDS. Data Recipient may use and/or disclose the LDS 
for its research activities only.  
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5. Term and Termination. 
a. Term. The term of this Agreement shall commence as of the Effective Date and 
shall continue for so long as Data Recipient retains the LDS, unless sooner 
terminated as set forth in this Agreement. 
b. Termination by Data Recipient. Data Recipient may terminate this agreement at 
any time by notifying the Data Provider and returning or destroying the LDS.  
c. Termination by Data Provider. Data Provider may terminate this agreement at any 
time by providing thirty (30) days prior written notice to Data Recipient.  
d. For Breach. Data Provider shall provide written notice to Data Recipient within 
ten (10) days of any determination that Data Recipient has breached a material 
term of this Agreement. Data Provider shall afford Data Recipient an opportunity 
to cure said alleged material breach upon mutually agreeable terms. Failure to 
agree on mutually agreeable terms for cure within thirty (30) days shall be 
grounds for the immediate termination of this Agreement by Data Provider. 
e. Effect of Termination. Sections 1, 4, 5, 6(e) and 7 of this Agreement shall survive 
any termination of this Agreement under subsections c or d.  
6. Miscellaneous. 
a. Change in Law. The parties agree to negotiate in good faith to amend this 
Agreement to comport with changes in federal law that materially alter either or 
both parties’ obligations under this Agreement. Provided however, that if the 
parties are unable to agree to mutually acceptable amendment(s) by the 
compliance date of the change in applicable law or regulations, either Party may 
terminate this Agreement as provided in section 6. 
b. Construction of Terms. The terms of this Agreement shall be construed to give 
effect to applicable federal interpretative guidance regarding the HIPAA 
Regulations. 
c. No Third Party Beneficiaries. Nothing in this Agreement shall confer upon any 
person other than the parties and their respective successors or assigns, any rights, 
remedies, obligations, or liabilities whatsoever. 
d. Counterparts. This Agreement may be executed in one or more counterparts, each 
of which shall be deemed an original, but all of which together shall constitute 
one and the same instrument. 
e. Headings. The headings and other captions in this Agreement are for convenience 
and reference only and shall not be used in interpreting, construing or enforcing 
any of the provisions of this Agreement. 
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IN WITNESS WHEREOF, each of the undersigned has caused this Agreement to be duly 
executed in its name and on its behalf. 
 
 
DATA PROVIDER    DATA RECIPIENT 
 
Signed:  Jean A Adams         Signed: Juli Molecavage 
Print Name: Jean A Adams   Print Name: Juli Molecavage 
 
Print Title:  ACIO     Print Title:  Student  
  
 
